Capula Management’s Surmodics SRDX Stock Holding History

Capula Management’s Portfolio SRDX Stock Details SRDX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q4	–	Sell	-132,536	Closed	-$5.14M	–	584
2024 Q3	$5.14M	Sell	132,536 -32,585	-20%	-$1.32M	0.05%	58
2024 Q2	$6.94M	Buy	+165,121	New	+$5.63M	0.06%	59

Other funds holding SRDX

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Qube Research & Technologies (QRT) London, United Kingdom $108B AUM 37.29% 1-Year Est. Return

SCM

Soleus Capital Management Greenwich, Connecticut $2.9B AUM 169.69% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Trigran Investments Northbrook, Illinois $545M AUM 56.2% 1-Year Est. Return

Gabelli Funds Rye, New York $15.7B AUM 36.4% 1-Year Est. Return

Capula Management's SRDX Position: Q4 2024 in Review

Capula Management sold out of Surmodics (SRDX) in Q4 2024, closing a stake of 132,536 shares — an estimated $5.14M sold.

Capula Management first reported a position in SRDX in Q2 2024 and held it in 2 quarters. The position peaked at $6.94M in Q2 2024. 139 funds tracked by Wall St. Rank hold SRDX as of Q4 2024.

Capula Management reported no remaining Surmodics position as of Q4 2024 after selling out during the quarter.
Capula Management sold 132,536 Surmodics shares in Q4 2024, an estimated $5.14M.
Capula Management first reported a position in Surmodics in Q2 2024 and held it in 2 quarters.
Capula Management's Surmodics position peaked at $6.94M in Q2 2024.
139 funds tracked by Wall St. Rank held Surmodics as of Q4 2024.

Based on Capula Management's 13F filing for Q4 2024, filed 13 Feb 2025.